Abbott Laboratories
Patent owner in reexamination·3 ex parte reexams
Abbott Laboratories's patents have been the subject of 3 USPTO ex parte reexaminations. Its patents are most often challenged by HyTest Oy dba HyTest Ltd. and Kenneth Sheehan. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.
Filings by year
Top requesters
Outcome track record
How reexams of this owner's patents resolve: claims confirmed, amended, mixed, or fully canceled.
- Certificate outcome split across every bucket
- Claim-survival rate
Defense metrics
Claim-survival rate, average pendency, and the open/closed split across every reexam of this owner's patents.
- Survival rate of closed proceedings
- Average pendency in months
Challengers & examiners
Which requesters most often challenge this owner's patents, and which examiners decide them.
- Top requesters
- Most frequent examiners
Recent reexaminations (3)
| Control # | Filed | Patent | Title | Requester | Status |
|---|---|---|---|---|---|
| 90/012,753 | Dec 26, 2012 | 7,090,879 | Nutritional Formula Containing Select Carotenoid Combinations | — | Closed |
| 90/012,377 | Jul 17, 2012 | 8,030,026 | Antibodies to Troponin I and Methods of Use Thereof | HyTest Oy dba HyTest Ltd. | Closed |
| 90/012,204 | Mar 22, 2012 | 5,827,526 | Use of Indigestible Oligosaccharides to Prevent Gastrointestinal Infections and Reduce Duration of Diarrhea in Humans | Kenneth Sheehan | Closed |
See the full reexam picture for Abbott Laboratories
Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.